Tianjin Lisheng Pharmaceutical Co Ltd (002393) — Capital Reinvestment Ratio
Tianjin Lisheng Pharmaceutical Co Ltd (002393) has a Capital Reinvestment Ratio of 0.07x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥287.81 Million) in capital expenditures (CN¥20.11 Million). See free cash flow generation of Tianjin Lisheng Pharmaceutical Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Tianjin Lisheng Pharmaceutical Co Ltd Capital Reinvestment Ratio (2007–2025)
This chart tracks Tianjin Lisheng Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 19 annual periods.
Annual Capital Reinvestment Ratio for Tianjin Lisheng Pharmaceutical Co Ltd (2007–2025)
Year-by-year Capital Reinvestment Ratio for Tianjin Lisheng Pharmaceutical Co Ltd from 2007 to 2025. For live market cap and broader valuation context, see 002393 market cap overview.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.08x | CN¥451.85 Million | CN¥37.46 Million | ▼ -86.4% |
| 2024 | 0.61x | CN¥88.26 Million | CN¥53.75 Million | ▲ +106.7% |
| 2023 | 0.29x | CN¥209.51 Million | CN¥61.72 Million | ▲ +138.6% |
| 2022 | 0.12x | CN¥331.38 Million | CN¥40.91 Million | ▼ -72.5% |
| 2021 | 0.45x | CN¥196.34 Million | CN¥88.24 Million | ▼ -65.9% |
| 2020 | 1.32x | CN¥76.37 Million | CN¥100.66 Million | ▲ +291.0% |
| 2019 | 0.34x | CN¥268.33 Million | CN¥90.46 Million | ▼ -47.5% |
| 2018 | 0.64x | CN¥162.69 Million | CN¥104.43 Million | ▲ +129.7% |
| 2017 | 0.28x | CN¥179.25 Million | CN¥50.09 Million | ▼ -64.6% |
| 2016 | 0.79x | CN¥173.60 Million | CN¥137.20 Million | ▼ -23.5% |
| 2015 | 1.03x | CN¥198.13 Million | CN¥204.60 Million | ▼ -74.3% |
| 2014 | 4.02x | CN¥72.24 Million | CN¥290.65 Million | ▲ +272.2% |
| 2013 | 1.08x | CN¥289.62 Million | CN¥313.11 Million | ▲ +20.8% |
| 2012 | 0.89x | CN¥250.72 Million | CN¥224.35 Million | ▼ -27.4% |
| 2011 | 1.23x | CN¥134.58 Million | CN¥165.94 Million | ▲ +230.1% |
| 2010 | 0.37x | CN¥186.55 Million | CN¥69.69 Million | ▲ +316.4% |
| 2009 | 0.09x | CN¥196.14 Million | CN¥17.60 Million | ▼ -82.5% |
| 2008 | 0.51x | CN¥126.59 Million | CN¥64.86 Million | ▲ +543.9% |
| 2007 | 0.08x | CN¥174.94 Million | CN¥13.92 Million | — |